Stock comparison
AMGEN INC is 71.6x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($196.28 B vs $2.74 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 71.6x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($196.28 B vs $2.74 B).
Market value leader
AMGN
AMGEN INC is 71.6x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($196.28 B vs $2.74 B).
Revenue leader
AMGN
TARS: $451.36M vs AMGN: $36.75B.
Profit leader
AMGN
TARS: -$66.00M vs AMGN: $7.71B.
Margin leader
AMGN
TARS: -14.6% vs AMGN: 21.0% net margin.
| Metric | TARS | AMGN |
|---|---|---|
| Market cap | $2.74 B | $196.28 B |
| US-listed rank | #1912 | #75 |
| Revenue (latest FY) | $451.36M | $36.75B |
| Net income (latest FY) | -$66.00M | $7.71B |
| Net margin | -14.6% | 21.0% |
| P/E (trailing FY) | - | 25.5x |
| SEC filings | 614 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 71.6x more valuable than Tarsus Pharmaceuticals, Inc. by market capitalization ($196.28 B vs $2.74 B).
In their latest fiscal years, Tarsus Pharmaceuticals, Inc. reported $451.36M in revenue while AMGEN INC reported $36.75B.
Full pages: Tarsus Pharmaceuticals, Inc. and AMGEN INC, or browse the full rankings.